Login| Sign Up| Help| Contact|

Patent Searching and Data


Matches 1 - 50 out of 1,276

Document Document Title
WO/2018/078005A1
The present invention relates to amido-substituted cyclohexane compounds of general formula (I) : in which A, R4, R6, R7, R8, R9, R10 and R11 are as defined herein, to methods of preparing said compounds, to intermediate compounds useful...  
WO/2018/077689A1
The present invention relates to a compound of an acridine derivate as well as of an organic semiconductor material an organic semiconductor layer, an electronic device comprising the acridine derivative, a device comprising an organic l...  
WO/2018/032967A1
Disclosed are a 9-phenylacridine macromolecule photosensitizer, and a preparing method and use thereof. The 9-phenylacridine macromolecule photosensitizer comprises at least one of the compounds having a structure as shown in formula (I)...  
WO/2018/033085A1
Disclosed are a compound using anthrone as a core and applications thereof in an organic electroluminescent component. The compound uses anthrone as a parent core, which is connected to an aromatic heterocyclic group, so that the molecul...  
WO/2018/020974A1
Provided are the following: a sulfonium salt which does not contain a toxic metal and which exhibits higher cationic polymerization performance and crosslinking performance than a tetrakis(pentafluorophenyl)borate salt; a heat- or photo-...  
WO/2018/006059A1
Alkaline phosphatase chemiluminescent substrate formulations are provided exhibiting rapid incubation periods and improved stability for use in immunoassays.  
WO/2017/216299A1
The object of the present invention are compounds comprising at least one donor group and at least one acceptor group, as described herein, which are characterized by a pronounced CT character. The invention also relates to the use there...  
WO/2017/215549A1
Disclosed are an organic electroluminescent compound and an application thereof. The structural formula of the compound is as shown in general formula (1). The material has good fluorescence quantum efficiency and electroluminescence eff...  
WO/2017/207596A1
The present invention relates to compounds of the formula (1) which are suitable for use in electronic devices, in particular organic electroluminescent devices, and to electronic devices, which comprise these compounds.  
WO/2017/205425A1
Described herein are molecules for use in organic light emitting diodes comprising at least one moiety A, at least one moiety D, and at least one moiety B.  
WO/2017/155102A1
Provided is a compound which comprises 2 or more donor groups having different structures and a linking group that links these donor groups, wherein the linking group is an aromatic group constituted from 1 or more benzene rings optional...  
WO/2017/115753A1
The purpose of the present invention is to provide an organic electroluminescence element having high light emission efficiency while controlling the light emission wavelength thereof. This bridged compound has a structure represented by...  
WO/2017/102063A1
The present invention relates to compounds of the formula (1) which are suitable for use in electronic devices, in particular organic electroluminescent devices, and to electronic devices which comprise these compounds.  
WO/2017/104797A1
The objective of a first invention of the present invention is to provide a radical generating catalyst that is capable of generating (producing) radicals under mild conditions. In order to achieve said objective, a first radical generat...  
WO/2017/057976A1
The present specification provides a spiro compound and an organic light emitting element comprising the same.  
WO/2017/059401A3
Described are compounds that inhibit androgen receptor action, pharmaceutical compositions including the compounds, and methods of using the compounds and compositions for treating disorders and conditions in a subject.  
WO/2017/051938A1
The present invention provides, by using a standard concentration-sensitivity graph and a protein analysis method in which a composite of an antibody-gene complex and an antigen and a marker material-secondary antibody complex is measure...  
WO/2017/040965A1
A lubricant composition includes a base oil present in an amount of greater than 70 parts by weight per 100 parts by weight of the lubricant composition and an antioxidant. The antioxidant has the structure: wherein each X is independent...  
WO/2017/029397A1
This invention provides a process for providing phosphoramidate derivatives, comprising performing a nucleophilic substitution reaction at phosphorous, where a phosphoryl chloride derivative is reacted with an oxime derivative to provide...  
WO/2017/031156A1
Method of using ureidomustine (BO-1055), a water-soluble NDA cross-linking agent, in the treatment of a cancer, selected from the group consisting of various types of human leukemia [such as acute myeloid leukemia (ALL) and acute B Lymph...  
WO/2017/031156A8
Method of using ureidomustine (BO-1055), a water-soluble NDA cross-linking agent, in the treatment of a cancer, selected from the group consisting of various types of human leukemia [such as acute myeloid leukemia (ALL) and acute B Lymph...  
WO2015044960A3
Compounds For Inhibition Of Unregulated Cell Growth The present invention relates to compounds of Formula I for inhibition or eradication of unregulated cell growth.  
WO/2016/197730A1
The present invention relates to an organic electroluminescent material, which has a structure as represented by formula (I). Compounds as represented by formula (I) have highly stable electron acceptor groups and electron donor groups, ...  
WO/2016/179702A1
The invention relates to compositions useful in the treatment of a head and neck cancer, the composition comprising a therapeutically effective amount of an acridinone compound having the formula (I): or a pharmaceutically acceptable sal...  
WO/2016/181844A1
In order to provide a π-conjugated compound that increases light-emission efficiency, this π-conjugated compound has: an absolute value for the difference between the lowest excited singlet energy level and the lowest excited triplet e...  
WO/2016/176222A1
The present invention provides therapeutic strategies for treatment of severe debilitating diseases associated with IFN-I due to cGAS activation. In one aspect, the invention provides compounds of Formula (I): [Formula should be inserted...  
WO/2016/173020A1
A conjugated compound containing a diphenyl sulfone phenyl structure, a method for preparing same, and use for fabricating a light emitting layer or an electronic transmission layer of an organic electroluminescent diode. The compound ha...  
WO/2016/168540A1
Compounds having activity as inhibitors of G12C mutant KRAS protein are provided. The compounds have the following structure (I):(I) or a pharmaceutically acceptable salt, stereoisomer or prodrug thereof, wherein A is a heterocyclic or h...  
WO/2016/168721A1
The invention provides dimeric quinacrine derivatives and related compounds and compositions, methods of treatment and syntheses. The novel compounds exhibit unexpected anticancer activity and are useful in the treatment of a variety of ...  
WO/2016/150799A1
We disclose novel asymmetric bis-acridines with antitumour activity. These compounds are useful for use in pharmaceuticals, particularly in the treatment or the prevention of neoplasms.  
WO/2016/146655A1
The present invention relates to the compound having Formula (I) or pharmaceutically acceptable salts or solvates thereof, and its use in treating and/or preventing a Tauopathy.  
WO/2016/116111A1
The present invention relates to a new class of substituted acridinium- and xanthenium-like fluorescent dyes having a 9-x-antracenium rings system. The new substituted fluorescent dyes may be attached to a linker, conjugated to carrier m...  
WO/2016/111196A1
A compound represented by general formula (1) is useful as a host and an assist dopant. R1 to R5 independently represent a hydrogen atom or a substituent other than a cyano group, and at least one of R1 to R5 represents a group represent...  
WO/2016/102412A1
Organic electronic device comprising an anode, a cathode and at least one emissive layer free of compounds of heavy atoms having an atomic number exceeding 40 comprising a compound of formula (1) wherein R1, is hydrogen, a C1-C18 alkyl g...  
WO/2016/083915A1
The present invention relates to a 4-hydroxquinoline compounds of the formula (I) wherein A is selected from diradicals of the formulae (A.1), (A.2), (A.3), (A.4), (A.5), and (A.6) wherein R 1, R 2a, R 2b, R 3, if present R 4a, R 4b, R 5...  
WO/2016/078738A1
The present invention relates to compounds of the formula (1) which are suitable for use in electronic devices, in particular organic electroluminescent devices, and to electronic devices which comprise these compounds.  
WO/2016/064671A2
There is provided a compound having Formula (I), Formula (II), Formula (III), Formula (IV), Formula (V), or Formula (VI).  
WO/2016/064671A3
There is provided a compound having Formula (I), Formula (II), Formula (III), Formula (IV), Formula (V), or Formula (VI).  
WO/2016/017757A1
The present invention addresses the problem of providing an organic electroluminescent element, etc. that makes it possible to suppress broadening of the absorption spectrum and light emission spectrum, improve light emission efficiency,...  
WO/2016/005979A1
A method of increasing survival of viral infected honeybees, reducing viral load or protecting the honeybees from death, wherein said virus is a ssRNA virus, comprising administering to the honeybees an antiviral effective amount of an a...  
WO/2015/199303A1
Provided are a compound represented by chemical formula I; an organic photoelectronic device comprising the same; and a display device comprising the organic photoelectronic device.  
WO/2015/129714A1
 A compound represented by general formula (1) is useful as a light-emitting material. R1, R3, and R5 represent fluorine atoms, or R1, R2, R4, and R5 represent fluorine atoms. The remaining R1-R6 represent groups represented by general...  
WO/2015/109451A1
The present invention mainly pertains to catalytic processes for the direct amination of 2, -bis(hydroxymethyl) tetrahydrofuran to obtain compounds containing the 8-oxa-3-azabicyclo (3.2.1) octane ring, in the presence of: a homogenous c...  
WO/2015/107119A1
The present invention relates to 4-azapodophyllotoxin analogs of formula (I) in which X, R1, R2, R3, R4 and Ar are as defined in claim 1, preferably a pharmaceutically acceptable salt thereof, optionally in the form of a solvate, a compo...  
WO/2015/091308A1
The present invention relates to a compound obtainable by the condensation of a polyol having 3-4 hydroxyl groups, adicarboxylic acid or a derivative thereof, an alkanolamine anda fatty acid, followed by reaction with an alkylating agent...  
WO/2015/080183A1
A compound represented by general formula (1) is useful as a light-emitting material. In general formula (1), zero to one of R1 to R5 represents a cyano group, one to five of R1 to R5 independently represent a group represented by genera...  
WO/2015/068987A1
Provided are an organic compound represented by chemical formula 1 in the specification (see image in the specification) and an organic electroluminescent element comprising the same.  
WO/2015/029354A1
[Problem] To provide a compound which emits fluorescence and delayed fluorescence as a material for a high efficiency organic electroluminescent element, and to further provide an organic photoluminescent element and a high efficiency, h...  
WO/2015/006174A1
Hydrophilic, high quantum yield, chemiluminescent acridinium compounds with increased light output, improved stability, fast light emission and decreased non specific binding are disclosed. The chemiluminescent acridinium esters possess ...  
WO/2014/206877A1
The compounds of formula (I), or its pharmaceutically acceptable salts, or any stereoisomer or mixture thereof, wherein: R1 and R1' are both H, or R1 and R1' are taken together forming a biradical of formula -CH2-C(R4)=CH-; R2 and R3 are...  

Matches 1 - 50 out of 1,276